Lensar (LNSR) Cash from Investing Activities Growth (1y) (2020 - 2026)
Lensar (LNSR) Cash from Investing Activities Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.11 Bn | 194.51 Bn | 7.27 Bn | -15.64% |
| 2 | Stryker | 129.85 Bn | 126.37 Bn | 4.50 Bn | -514.42% |
| 3 | Medtronic | 119.93 Bn | 110.71 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 74.18 Bn | 73.64 Bn | 3.85 Bn | -73.71% |
| 5 | Edwards Lifesciences | 52.54 Bn | 48.29 Bn | 1.35 Bn | -12.26% |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn | 618.55% |
| 7 | GE HealthCare Technologies | 34.25 Bn | 32.14 Bn | 2.18 Bn | 48.43% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 91.33% |
| 9 | Steris | 23.29 Bn | 22.80 Bn | 684.20 Mn | 0.00% |
| 10 | Lensar | 104.16 Mn | 90.59 Mn | 9.78 Mn | 112.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112.88% |
| Mar 31, 2026 | 653.30% |
| Dec 31, 2025 | 113.10% |
| Sep 30, 2025 | 541.99% |
| Jun 30, 2025 | -270.52% |
| Mar 31, 2025 | 143.31% |
| Dec 31, 2024 | 150.24% |
| Sep 30, 2024 | -45,150.00% |
| Jun 30, 2024 | -1,017.13% |
| Mar 31, 2024 | -15,225.00% |
| Dec 31, 2023 | -6,856.14% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -1,710.00% |
| Mar 31, 2023 | 82.61% |
| Dec 31, 2022 | 63.46% |
| Sep 30, 2022 | 96.88% |
| Jun 30, 2022 | 50.00% |
| Mar 31, 2022 | 59.65% |
| Dec 31, 2021 | -48.57% |
| Sep 30, 2021 | -557.14% |